دورية أكاديمية

Outcomes of Iris-Claw IOL Implantation in Patients with Marfan's Syndrome in Jordan.

التفاصيل البيبلوغرافية
العنوان: Outcomes of Iris-Claw IOL Implantation in Patients with Marfan's Syndrome in Jordan.
المؤلفون: Al-Dwairi RA; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Shihadeh WA; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Alqudah AA; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Alqudah NM; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Msallam M; Department of Ophthalmology, King Abdullah University Hospital, Irbid, 22110, Jordan., Alrazem F; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Alshamarti S; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Shannak Z; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Abueid M; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan., Aleshawi A; Department of Special Surgery, Division of Ophthalmology, Faculty of Medicine, Jordan University of Science & Technology, Irbid, 22110, Jordan.
المصدر: Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2022 Nov 17; Vol. 16, pp. 3811-3819. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101321512 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5467 (Print) Linking ISSN: 11775467 NLM ISO Abbreviation: Clin Ophthalmol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Auckland : Dove Medical Press, c2007-
مستخلص: Objective: The management of ocular complications of Marfan's syndrome, especially ectopia lentis, is challenging. In this study, we present the effectiveness and the safety of iris-claw intraocular lens (IOL) implantation along with lensectomy for those patients. Also, we compare the practice of implanting these IOLs either in the anterior chamber of retropupillary.
Methods: Retrospectively, we included all patients with Marfan's syndrome who underwent lensectomy with iris-claw IOL implantation as a result of ectopia lentis. The patients were categorized into two groups: anterior chamber iris claw IOL and retropupillary iris-claw IOL. The clinical and demographic data, the visual outcome and postoperative complications were compared.
Results: Eighteen eyes of 10 patients were included in the study. The mean age of the patients was 19.1 years. Six patients were males. The iris-claw IOL was implanted anteriorly in 13 eyes. The visual outcome was comparable between both groups and most patients achieved improvement in the visual acuity. In addition, the postoperative complications developed similarly in both groups. However, all cases of IOL disenclavation (6 cases) developed in the anterior group. It is revealed that the age of the patient was the most significant factor affecting the occurrence of IOL disenclavation.
Conclusion: Iris-claw IOL (either anteriorly or retropupillary) is an effective and relatively safe method in treating ectopia lentis in patients with Marfan's syndrome. In younger patients, anterior iris-claw IOL is safer than retropupillary iris-claw IOL as the risk of disenclavation is higher in younger patients.
Competing Interests: The authors have no financial ties or conflicts of interest to disclose.
(© 2022 Al-Dwairi et al.)
References: Am J Med Genet. 1996 Apr 24;62(4):417-26. (PMID: 8723076)
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1236-40. (PMID: 16505064)
Invest Ophthalmol Vis Sci. 1998 Jan;39(1):84-93. (PMID: 9430549)
J Refract Surg. 2006 Jan-Feb;22(1):99-101. (PMID: 16450455)
Biochem J. 1999 Jun 15;340 ( Pt 3):693-701. (PMID: 10359653)
J Pediatr Ophthalmol Strabismus. 2015 Sep-Oct;52(5):269-81. (PMID: 26181899)
Am J Hum Genet. 2007 Sep;81(3):454-66. (PMID: 17701892)
Acta Ophthalmol. 2017 Mar;95(2):170-174. (PMID: 27535343)
BMC Cardiovasc Disord. 2017 Jul 19;17(1):193. (PMID: 28724353)
Ophthalmology. 2010 Aug;117(8):1479-85. (PMID: 20466427)
Eur J Ophthalmol. 2014 May-Jun;24(3):352-7. (PMID: 24057936)
Am J Ophthalmol. 1973 Mar;75(3):405-20. (PMID: 4633235)
Acta Ophthalmol. 2014 Feb;92(1):e82-3. (PMID: 23786577)
Int Ophthalmol. 2017 Aug;37(4):1025-1030. (PMID: 27709371)
Int Med Case Rep J. 2016 Jun 17;9:149-53. (PMID: 27382335)
Arch Ophthalmol. 1966 Oct;76(4):512-22. (PMID: 4959153)
J AAPOS. 2005 Jun;9(3):240-2. (PMID: 15956943)
J Ophthalmic Vis Res. 2019 Jan-Mar;14(1):71-77. (PMID: 30820290)
Curr Opin Ophthalmol. 2005 Feb;16(1):57-60. (PMID: 15650581)
J Med Genet. 2010 Jul;47(7):476-85. (PMID: 20591885)
PLoS One. 2017 Sep 20;12(9):e0183370. (PMID: 28931008)
Arq Bras Oftalmol. 2017 Mar-Apr;80(2):114-117. (PMID: 28591285)
Ophthalmol Ther. 2022 Apr;11(2):771-784. (PMID: 35149965)
Ophthalmic Genet. 2000 Mar;21(1):9-15. (PMID: 10779844)
Ophthalmology. 2003 Jul;110(7):1344-8. (PMID: 12867389)
J Clin Invest. 1995 Feb;95(2):874-80. (PMID: 7860770)
Lancet. 2005 Dec 3;366(9501):1965-76. (PMID: 16325700)
Br J Ophthalmol. 2012 Mar;96(3):419-21. (PMID: 21791507)
J AAPOS. 2012 Feb;16(1):92-4. (PMID: 22370675)
Ophthalmology. 2008 Jan;115(1):67-72. (PMID: 17481735)
فهرسة مساهمة: Keywords: Artisan; Marfan’s syndrome; ectopia lentis; retropupillary
تواريخ الأحداث: Date Created: 20221124 Latest Revision: 20221125
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC9677929
DOI: 10.2147/OPTH.S385352
PMID: 36419564
قاعدة البيانات: MEDLINE
الوصف
تدمد:1177-5467
DOI:10.2147/OPTH.S385352